X0609 4 2026-08-14 0001635088 Roivant Sciences Ltd. ROIV 0001750050 Sukhatme Mayukh true C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true true President & CIO false Common Shares 2026-08-14 4 M 0 243177 3.85 A 18873916 D Common Shares 2026-08-14 4 S 0 243177 36.23 D 18630739 D Common Shares 2026-08-17 4 M 0 284707 3.85 A 18915446 D Common Shares 2026-08-17 4 S 0 284707 36.25 D 18630739 D Common Shares 2026-08-18 4 M 0 105141 3.85 A 18735880 D Common Shares 2026-08-18 4 S 0 105141 36.59 D 18630739 D Common Shares 2026-08-18 4 M 0 31801 3.85 A 18662540 D Common Shares 2026-08-18 4 S 0 31801 37.18 D 18630739 D Common Shares 3.85 2026-08-14 4 M 0 243177 0 D 2032-04-19 Common Shares 243177 13981186 D Common Shares 3.85 2026-08-17 4 M 0 284707 0 D 2032-04-19 Common Shares 284707 13696479 D Common Shares 3.85 2026-08-18 4 M 0 136942 0 D 2032-04-19 Common Shares 136942 13559537 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $37.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. Award of stock options to purchase Common Shares that is fully vested. Exhibit 24 - Power of Attorney By: /s/ Sam Kaplan, as Attorney-in-Fact for Mayukh Sukhatme 2026-08-18